RemeGen Co., Ltd.
REGMF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $86,661 | $571,985 | $525,969 | $507,987 |
| % Growth | -84.8% | 8.7% | 3.5% | – |
| Cost of Goods Sold | $13,414 | $86,988 | $88,031 | $101,974 |
| Gross Profit | $73,247 | $484,996 | $437,938 | $406,013 |
| % Margin | 84.5% | 84.8% | 83.3% | 79.9% |
| R&D Expenses | $34,157 | $318,332 | $328,885 | $402,819 |
| G&A Expenses | $0 | $56,132 | $90,180 | $82,084 |
| SG&A Expenses | $52,194 | $334,195 | $336,421 | $406,875 |
| Sales & Mktg Exp. | $0 | $275,085 | $250,696 | $326,054 |
| Other Operating Expenses | $1 | $23,877 | $22,379 | -$3,887 |
| Operating Expenses | $86,352 | $676,404 | $687,684 | $805,807 |
| Operating Income | -$13,105 | -$191,408 | -$249,746 | -$399,794 |
| % Margin | -15.1% | -33.5% | -47.5% | -78.7% |
| Other Income/Exp. Net | -$1,089 | -$4,017 | -$4,398 | $2,859 |
| Pre-Tax Income | -$14,194 | -$195,424 | -$254,144 | -$396,934 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$14,194 | -$195,424 | -$254,144 | -$396,934 |
| % Margin | -16.4% | -34.2% | -48.3% | -78.1% |
| EPS | -0.025 | -0.37 | -0.46 | -0.74 |
| % Growth | 93.2% | 19.6% | 37.8% | – |
| EPS Diluted | -0.025 | -0.37 | -0.46 | -0.74 |
| Weighted Avg Shares Out | 561,844 | 530,810 | 552,488 | 536,229 |
| Weighted Avg Shares Out Dil | 561,844 | 530,810 | 552,488 | 536,228 |
| Supplemental Information | – | – | – | – |
| Interest Income | $159 | $0 | $0 | $0 |
| Interest Expense | $2,137 | $19,564 | $19,807 | $16,327 |
| Depreciation & Amortization | $0 | $63,330 | $57,752 | $57,752 |
| EBITDA | -$12,130 | -$105,333 | -$169,176 | -$328,629 |
| % Margin | -14% | -18.4% | -32.2% | -64.7% |